August 24, 2020 – Brainsway has received another FDA clearance for its deep TMS machine! This time to treat smoking addiction in adults. Achieve TMS East uses Brainsway machines in all of of our offices.
“CRESSKILL, N.J. and JERUSALEM, Israel, August 24, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company’s deep transcranial magnetic stimulation (Deep TMS) system for its use as an aid in short-term smoking cessation in adults.
“This FDA clearance represents a significant milestone for BrainsWay and our Deep TMS platform technology,” stated Christopher von Jako, Ph.D., President and Chief Executive Officer of BrainsWay.”